V012-1054 Screening compound: 3-[4-(2-chloro-6-fluorobenzoyl)piperazin-1-yl]-4-methoxy-N-(4-methoxyphenyl)-N-methylbenzene-1-sulfonamide

V012-1054 Screening compound: 3-[4-(2-chloro-6-fluorobenzoyl)piperazin-1-yl]-4-methoxy-N-(4-methoxyphenyl)-N-methylbenzene-1-sulfonamide
V012-1054 Screening compound: 3-[4-(2-chloro-6-fluorobenzoyl)piperazin-1-yl]-4-methoxy-N-(4-methoxyphenyl)-N-methylbenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-1054
3-[4-(2-chloro-6-fluorobenzoyl)piperazin-1-yl]-4-methoxy-N-(4-methoxyphenyl)-N-methylbenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-1054

Molecular Formula

C26H27ClFN3O5S (C26 H27 ClFN3 O5 S)

Compound Name

3-[4-(2-chloro-6-fluorobenzoyl)piperazin-1-yl]-4-methoxy-N-(4-methoxyphenyl)-N-methylbenzene-1-sulfonamide

IUPAC name

3-[4-(2-chloro-6-fluorobenzoyl)piperazin-1-yl]-4-methoxy-N-(4-methoxyphenyl)-N-methylbenzene-1-sulfonamide

SMILES

CN(c(cc1)ccc1OC)S(c(cc1)cc(N(CC2)CCN2C(c(c(F)ccc2)c2Cl)=O)c1OC)(=O)=O

InChI

InChI=1S/C26H27ClFN3O5S/c1-29(18-7-9-19(35-2)10-8-18)37(33,34)20-11-12-24(36-3)23(17-20)30-13-15-31(16-14-30)26(32)25-21(27)5-4-6-22(25)28/h4-12,17H,13-16H2,1-3H3

InChI Key

DICXXBLUXPKFAA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19950470

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

548.03

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.772

Distribution Coefficient, logD

4.772

Water Solubility, LogSw

-5.13

Polar Surface Area

67.842

Acid Dissociation Constant (pKa)

28.17

Base Dissociation Constant (pKb)

0.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

V012-1054 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V012-1054 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-1054?
Check Price and Availability of V012-1054, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-1054 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-1054
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-1054
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-1054 available by request